Summary
Molecular defects in the gene encoding the enzyme iduronate-2-sulfatase (IDS) result in Hunter disease (mucopolysaccharidosis type II, MPS II). To determine the molecular basis of MPS II in Thailand, the IDS gene was analysed in 20 Thai patients with Hunter syndrome from 18 unrelated families. A total of 19 different mutations, including 9 missense mutations, 3 nonsense mutations, 3 splice site alterations, 1 deletion, 2 indels, and 1 rearrangement were identified, 8 of which were novel (p.R101C, p.D148V, p.G224A, p.K227E, p.E254X, p.W337X, c.440_442delinsTT and c.720_731delinsTTTCAGATGTTCTCCCCAG). Evaluation of the IDS activity of two hemizygous variants identified in the same patient, p.R101C and p.R468Q, by expression of IDS with the individual mutations in COS 7 cells indicated that only the p.R468Q mutation affected IDS protein activity. Two exonic mutations, c.257C>T (p.P86L) and c.418G>A, were found to activate multiple cryptic splice sites, resulting in aberrantly spliced transcripts. Thus, MPS II in Thailand is caused by a diverse set of defects affecting both IDS protein production and activity.
Abbreviations
- ESE:
-
exonic splicing enhancer
- IDS:
-
iduronate 2-sulfatase
- IDS :
-
iduronate 2-sulfatase gene
- IDS-2 :
-
iduronate 2-sulfatase pseudogene
References
Alves S, Mangas M, Prata MJ, et al (2006) Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations. J Inherit Metab Dis 29: 743–754.
Bondeson ML, Malmgren H, Dahl N, Carlberg BM, Pettersson U. (1995a) Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome. Eur J Hum Genet 3: 219–227.
Bondeson ML, Dahl N, Malmgren H, et al (1995b) Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Mol Genet 4: 615–621.
Bunge S, Steglich C, Beck M, et al (1992) Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet 1: 335–339.
Chang JH, Lin SP, Lin SC, et al (2005) Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II). Hum Genet 116: 160–166.
Dou W, Peng C, Zheng JK, Gu XF (2007) Detection of two novel mutations of iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II. Hereditas (China) 29: 37–40.
Filocamo M, Bonuccelli G, Corsolini F, Mazzotti R, Cusano R, Gatti R (2001) Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: New mutations in the iduronate-2-sulfatase (IDS) gene. Hum Mutat 18: 164–165.
Flomen RH, Green EP, Green PM, Bentley DR, Giannelli F (1993) Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene. Hum Mol Genet 2: 5–10.
Froissart R, Maire I, Millat G, et al (1998) Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients. Clin Genet 53: 362–368.
Hopwood JJ, Bunge S, Morris CP, et al (1993) Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat 2: 435–442.
Isogai K, Sukegawa K, Tomatsu S, et al (1998) Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease). J Inherit Metab Dis 21: 60–70.
Kato T, Kato Z, Kuratsubo I, et al (2005) Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II. J Hum Genet 50: 395–402.
Kim CH, Hwang HZ, Song SM, et al (2003) Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: Identification of 13 novel mutations. Hum Mutat 21: 449–450.
Lissens W, Seneca S, Liebaers I (1997) Molecular analysis in 23 Hunter disease families. J Inherit Metab Dis 20: 453–456.
Lualdi S, Regis S, Di Rocco M, et al (2005) Characterization of iduronate-2-sulfatase gene-pseudogene recombinations in eight patients with mucopolysaccharidosis type II revealed by a rapid PCR-based method. Hum Mutat 25: 491–497.
Lualdi S, Pittis MG, Regis S, et al (2006) Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts. J Mol Med 84: 692–700.
Millat G, Froissart R, Cudry S, Bonnet V, Maire I, Bozon D (1998) COS cell expression studies of P86L, P86R, P480L and P480Q Hunter’s disease-causing mutations. Biochim Biophys Acta 1406: 214–218.
Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3421–3452.
Popowska E, Rathmann M, Tylki-Szymanska A, et al (1995) Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mutat 5: 97–100.
Rathmann M, Bunge S, Steglich C, Schwinger E, Gal A. (1995) Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28. Hum Genet 95: 34–38.
Rathmann M, Bunge S, Beck M, Kresse H, Tylki-Szymanska A, Gal A (1996) Mucopolysaccharidosis type II (Hunter syndrome): mutation “hot spots” in the iduronate-2-sulfatase gene. Am J Hum Genet 59: 1202–1209.
Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15: 7155–7174.
Stenson PD, Ball EV, Mort M, et al (2003) Human gene mutation database (HGMD): 2003 udate. Hum Matat 21: 577–581.
Timms KM, Lu F, Shen Y, et al (1995) 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res 5: 71–78.
Sukegawa K, Tomatsu S, Tamai K, et al (1992) Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun 183: 809–813.
Sukegawa-Hayasaka K, Kato Z, Nakamura H, et al (2006) Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis. J Inherit Metab Dis 29: 755–761.
Vafiadaki E, Cooper A, Heptinstall LE, Hatton CE, Thornley M, Wraith JE (1998) Mutation analysis in 57 unrelated patients with MPS II (Hunter’s disease). Arch Dis Child 79: 237–241.
Voznyi YV, Keulemans JL, van Diggelen OP (2001) A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis 24: 675–680.
Whitley CB, Anderson RA, Aronovich EL, et al (1993) Caveat to genotype–phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat 2: 235–237.
Acknowledgements
The authors are grateful to the families of the patients for their assistance in this investigation and to the Chulabhorn Research Institute and Mahidol University for financial support. J.S. is a Senior Research Scholar of the Thailand Research Fund. D.W. and P.S. are recipients of Research Career Development Awards from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Douglas Brooks
Competing interests: None declared
References to electronic databases: Hunter syndrome: OMIM 309900. HUGO gene name: IDS. Iduronate-2-sulfatase (IDS): EC 3.1.6.13. Genbank accession number for IDS gene: AH002847.
Rights and permissions
About this article
Cite this article
Keeratichamroen, S., Ketudat Cairns, J.R., Wattanasirichaigoon, D. et al. Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome. J Inherit Metab Dis 31 (Suppl 2), 303–311 (2008). https://doi.org/10.1007/s10545-008-0876-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0876-z